Innovative therapeutics

About us

Philip Lo Scalzo

Senior Vice President, Chief Compliance Officer

Philip Lo Scalzo

Mr. Lo Scalzo joined BioMarin in 2007 and serves as Vice President of Corporate Compliance & Ethics and Corporate Compliance Officer. He is responsible for creating and maintaining the company’s global compliance program and overseeing its internal audit function. His responsibilities include: chairing the Corporate Compliance Committee; overseeing the development and implementation of corporate compliance policies; training employees and partners; scoping and executing internal audits, including audits of third-party vendors; coordinating enterprise risk assessments and analysis; monitoring promotional events and other interactions with healthcare professionals; managing investigations; and implementing corrective actions.

Prior to this role, Mr. Lo Scalzo served as BioMarin’s Deputy General Counsel, responsible for a variety of legal and corporate compliance-related matters.  Before joining BioMarin, Mr. Lo Scalzo spent four years at Sanofi-Aventis, where he served as an Assistant General Counsel supporting the organization’s cardiovascular operations team, corporate compliance department, litigation, and human resources groups. Prior to joining Sanofi-Aventis, Mr. Lo Scalzo was an associate attorney in the New York office of Sedgwick, Detert, Moran & Arnold, where his practice primarily focused on defending pharmaceutical product liability cases. Mr. Lo Scalzo received a J.D. from Brooklyn Law School and a B.A. in History from Boston College.

-Updated April 2016



Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS



Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361

Global Medical Information

Contact Global Medical Information